AstraZeneca PLC

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0009895292
GBP
138.96
-5.06 (-3.51%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
ECO Animal Health Group Plc
Shield Therapeutics Plc
Arecor Therapeutics Plc
Alliance Pharma Plc
Redx Pharma Plc
Indivior PLC
Destiny Pharma Plc
GSK Plc
AstraZeneca PLC
Dechra Pharmaceuticals Plc
Benchmark Holdings Plc

Why is AstraZeneca PLC ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is AstraZeneca PLC for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
AstraZeneca PLC
17.31%
1.84
25.79%
FTSE 100
13.98%
1.15
13.60%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
15.61%
EBIT Growth (5y)
21.72%
EBIT to Interest (avg)
4.36
Debt to EBITDA (avg)
1.85
Net Debt to Equity (avg)
0.61
Sales to Capital Employed (avg)
0.64
Tax Ratio
16.21%
Dividend Payout Ratio
47.19%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
12.02%
ROE (avg)
15.16%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
6.33
EV to EBIT
23.78
EV to EBITDA
16.74
EV to Capital Employed
4.65
EV to Sales
5.52
PEG Ratio
1.06
Dividend Yield
214.01%
ROCE (Latest)
19.55%
ROE (Latest)
21.94%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend

Here's what is working for AstraZeneca PLC

Net Sales - Quarterly
At GBP 10,000 MM has Grown at 11.68 %
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (GBP MM)

Profit Before Tax less Other Income (PBT) - Quarterly
At GBP 2,234 MM has Grown at 37.69 %
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (GBP MM)

Profit After Tax (PAT) - Quarterly
At GBP 1,839 MM has Grown at 20.3 %
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (GBP MM)

Operating Cash Flow - Annually
Highest at GBP 8,553.14 MM and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (GBP MM)

Operating Profit to Interest - Quarterly
Highest at 10.90 times
in each of the last 5 periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest (GBP MM)

Net Sales - Quarterly
Highest at GBP 10,000 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (GBP MM)

Operating Profit (PBDIT) - Quarterly
Highest at GBP 3,549 MM.
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (GBP MM)

Operating Profit Margin - Quarterly
Highest at 35.49%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales (GBP MM)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at GBP 2,234 MM.
in the last five periods
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (GBP MM)

Profit After Tax (PAT) - Quarterly
Highest at GBP 1,839 MM.
in the last five periods
MOJO Watch
Near term PAT trend is positive

PAT (GBP MM)

Earnings per Share (EPS) - Quarterly
Highest at GBP 1.10
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (GBP)

Here's what is not working for AstraZeneca PLC

Debt-Equity Ratio - Half Yearly
Highest at 0.68 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Dividend Payout Ratio (DPR) - Annually
Lowest at 73.66 %
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)